Malaria in Pregnancy Working Group (MiPWG)
- Reference documents
- Co-Chairs :
- Dr Viviana Mangiaterra - The Global Fund
Dr Elaine Roman - JHPIEGO
- RBM Secretariat Focal point:
- Dr Silvia Ferazzi
Tel.: +41 22 791 2482
- Next meeting:
- The Roll Back Malaria (RBM) MiP Working Group and the Malaria in Pregnancy Consortium will be organizing a 'Call to Action' symposium for the scale-up of IPTp to be held at the 63rd Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) in New Orleans, Louisiana, USA.
View the draft agenda
MPWG Work Streams:
Purpose / Rationale:
The purpose of the Malaria in Pregnancy Working Group (MiP WG) is to provide the RBM Partnership with strategic advice on best practices for scaling up interventions for the prevention and control of malaria during pregnancy towards the achievement of RBM targets and MDGs.
The MiP WG was established by the RBM Board in May 2003 to advance the efforts of partners in the prevention and control of malaria during pregnancy. Since its establishment, the MiP Working Group has played an important role in the development of the AFRO Strategic Framework for the Prevention and Control of Malaria during Pregnancy and has been instrumental in supporting countries to adopt the MiP strategy and rallying partners to support its implementation in countries.
In May 2003, a terms of reference (TOR) for the MiP WG was developed in accordance with the RBM partnership strategic plan for "going to scale" with implementation of key interventions for the control of malaria during pregnancy. This current TOR is a fourth revision of that developed in 2003 following the RBM Change Initiative and new strategic direction of the RBM Partnership proposed at the 11th RBM Board Meeting.
Areas of Focus:
The MiP WG promotes WHO's three evidence-based strategies for the prevention and treatment of malaria in pregnancy in stable malaria transmission countries: the delivery, distribution and routine use of insecticide-treated nets (ITNs) in pregnant women, the scale up of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) and appropriate case management through prompt and effective diagnosis and treatment of malaria in pregnant women.
This three-pronged approach should be delivered through routine focused antenatal care (FANC) as part of a comprehensive package of evidence-based services for all pregnant women. At present, WHO recommends at least four antenatal visits during pregnancy, and each visit should be seen as an opportunity to deliver MiP services.
Functions of the Working Group
The MiP Working Group will have the following functions:
1. Advise RBM partnership mechanisms on consensus strategies to achieve GMAP targets regarding MiP interventions (IPTp or IST, ITNs, case management)
2. Support country MiP programs to advocate for appropriate interventions for effective MiP control and scale-up programming efforts through:
- promoting collaboration and information sharing on MiP
- providing practical advice on policy that is context specific to Asia Pacific, Latin America and Africa
- supporting multicenter MiP studies in the regions
- supporting Ministries of Health to strengthen collaboration among Malaria Control, Reproductive, Maternal, Newborn and Child Health (RMNCH), HIV/AIDS, EPI and Nutrition programs for integrated policy and programming
- advocating for a stronger ANC platform for the delivery of MiP interventions
- bridging the gaps between technical and programmatic support at country level
- advocating for, promoting and supporting appropriate community interventions to increase the uptake of MiP interventions
3. Identify critical strategic programmatic and policy barriers, as well as knowledge gaps, for reaching universal access by:
- Outlining an operational research agenda to address the challenges of implementing MiP interventions
- Identifying strategies for addressing capacity gaps
- Identifying strategies for addressing issues with commodities
The MiP WG will also assign responsibilities to WG members of partners for action.
4. Support existing MiP coordination mechanisms by synthesizing and disseminating country experiences and best practices related to scaling-up MiP interventions.
5. Identify linkages with research for effective implementation and policy development. Disseminate outcomes produced by research activities and routine health information system submitted by countries to guide policy.
6. Interface and share relevant information with other RBM mechanisms to ensure strategic harmonization in resource mobilisation, implementation support and progress tracking (MAWG, MERG, HWG, PSMWG) to reach GMAP targets.
For further information, please refer to the MiPWG Revised Terms of Reference adopted in January 2014 following the 25th RBM Partnership Board meeting.